Connect
MJA
MJA

Psychotropic medication in pregnancy

Roisin N Worsley, Heather Gilbert and Jayashri Kulkarni
Med J Aust 2013; 199 (10) || doi: 10.5694/mja13.10719
Published online: 18 November 2013

To the Editor: The report by O’Donnell and colleagues on the increasing rate of mental illness in parents of infants highlights a very important issue and is consistent with overseas studies that suggest there is increasing use of psychotropic medication in pregnancy.1,2

The full article is accessible to AMA
members and paid subscribers.
Login to MJA or subscribe now.


  • Monash Alfred Psychiatry Research Centre, Monash University, Melbourne, VIC.


Correspondence: roisin.worsley@monash.edu

Competing interests:

No relevant disclosures.

  • 1. O’Donnell M, Anderson D, Morgan VA, et al. Trends in pre-existing mental health disorders among parents of infants born in Western Australia from 1990 to 2005. Med J Aust 2013; 198: 485-488. <MJA full text>
  • 2. Epstein RA, Bobo WV, Shelton RC, et al. Increasing use of atypical antipsychotics and anticonvulsants during pregnancy. Pharmacoepidemiol Drug Saf 2013; 22: 794-801.
  • 3. Kulkarni J, McCauley-Elsom K, Marston N, et al. Preliminary findings from the National Register of Antipsychotic Medication in Pregnancy. Aust N Z J Psychiatry 2008; 42: 38-44.
  • 4. Miller LJ, Finnerty M. Sexuality, pregnancy and childrearing among women with schizophrenia-spectrum disorders. Psychiatr Serv 1996; 47: 502-506.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.